Income Statement Peptron, Inc.

Stocks

A087010

KR7087010005

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2026-06-12			5-day change	1st Jan Change
230,000.00 ^KRW	-3.16%		-13.70%	-9.45%

25-08-05	Peptron, Inc. announced that it has received KRW 24.17749 billion in funding from LS SECURITIES Co., Ltd. and other investors	CI
25-07-28	Peptron to divest 24 billion won worth of own shares	RE

85a9c0abef3410c0221d4fe.1us0b7MwMgKvj3PKRiVu1rq9nqnNc4ST4PxFyT_EBdY.j7NVKfB9a0_44Tb4DnNZh47H_5CoPeLLsc8Ek1GQdqWlvHw44gRzTebhOg

Published financial data: PEPTRON, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	6.62B	5.81B	3.34B	3.15B	5.63B
Other Revenues, Total	10	-	-	-	-
Total Revenues	6.62B	5.81B	3.34B	3.15B	5.63B
Cost of Goods Sold, Total	2.16B	2.54B	2.29B	2.21B	4.29B
Gross Profit	4.47B	3.27B	1.05B	937M	1.34B
Selling General & Admin Expenses, Total	5B	4.86B	5.21B	4.92B	6.59B
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	14.84B	13.37B	11.44B	12.14B	15.45B
Depreciation & Amortization - (IS)	177M	168M	163M	282M	398M
Amortization of Goodwill and Intangible Assets - (IS)	102M	101M	118M	124M	162M
Other Operating Expenses, Total	20.12B	18.5B	16.94B	17.47B	22.6B
Operating Income	-15.66B	-15.23B	-15.88B	-16.53B	-21.26B
Interest Expense, Total	-36.84M	-280M	-396M	-473M	-1.32B
Interest And Investment Income	475M	423M	242M	672M	4.43B
Net Interest Expenses	439M	143M	-154M	199M	3.11B
Currency Exchange Gains (Loss)	192M	192M	96.06M	229M	-103M
Other Non Operating Income (Expenses)	-244M	-685K	1.75M	109M	51.42M
EBT, Excl. Unusual Items	-15.27B	-14.89B	-15.94B	-15.99B	-18.2B
Gain (Loss) On Sale Of Investments	5.28M	7.1M	2.83M	-2.47B	3.99B
Gain (Loss) On Sale Of Assets	-913K	-162M	3.47M	-3.15B	-124M
Asset Writedown	-15.96M	-19.49M	-7.05M	-8.71M	-1K
EBT, Incl. Unusual Items	-15.28B	-15.07B	-15.94B	-21.62B	-14.33B
Income Tax Expense	-242M	-4.21M	-18.94M	414M	-503M
Earnings From Continuing Operations	-15.04B	-15.06B	-15.92B	-22.03B	-13.82B
Net Income to Company	-15.04B	-15.06B	-15.92B	-22.03B	-13.82B
Net Income - (IS)	-15.04B	-15.06B	-15.92B	-22.03B	-13.82B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-15.04B	-15.06B	-15.92B	-22.03B	-13.82B
Net Income to Common Excl. Extra Items	-15.04B	-15.06B	-15.92B	-22.03B	-13.82B
Per Share Items
Net EPS - Basic	-729.24	-730.25	-773.61	-1.06K	-595.09
Basic EPS - Continuing Operations	-729.24	-730.25	-773.61	-1.06K	-595.09
Basic Weighted Average Shares Outstanding	20.63M	20.63M	20.58M	20.77M	23.23M
Net EPS - Diluted	-729.24	-730.25	-773.61	-1.06K	-595.09
Diluted EPS - Continuing Operations	-729.24	-730.25	-773.61	-1.06K	-595.09
Diluted Weighted Average Shares Outstanding	20.63M	20.63M	20.58M	20.77M	23.26M
Normalized Basic EPS	-462.75	-451.24	-484.06	-481.11	-489.6
Normalized Diluted EPS	-462.75	-451.24	-484.06	-481.11	-488.96
Supplemental Items
EBITDA	-12.15B	-10.17B	-12.99B	-13.84B	-18.54B
EBITA	-15.56B	-15.13B	-15.77B	-16.4B	-21.1B
EBIT	-15.66B	-15.23B	-15.88B	-16.53B	-21.26B
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	1.58	0.03	0.12	-1.92	3.51
Normalized Net Income	-9.55B	-9.31B	-9.96B	-9.99B	-11.37B
Supplemental Operating Expense Items
Advertising Expense	8.59M	15.58M	8.29M	7.41M	14.99M
Selling and Marketing Expenses	1.63B	1.42B	1.34B	1.16B	1.39B
Research And Development Expense From Footnotes	14.84B	13.37B	11.44B	12.14B	15.45B
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Maintenance & Repair Expenses, Total	76.79M	49.15M	86.91M	170M	189M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.64B	5.04B	4.26B	1.05B	4.38B
Short Term Investments	23.5B	9.6B	718M	109B	75.2B
Trading Asset Securities, Total	2.1B	2.6B	-	13.95B	27.34B
Total Cash And Short Term Investments	30.24B	17.24B	4.98B	124B	107B
Accounts Receivable, Total	387M	371M	415M	331M	612M
Other Receivables	249M	163M	29.85M	334M	580M
Notes Receivable	-	2.58B	999M	-	1.63B
Total Receivables	636M	3.11B	1.44B	665M	2.82B
Inventory	705M	814M	172M	258M	1.77B
Prepaid Expenses	33.24M	185M	49.6M	244M	1.37B
Other Current Assets, Total	1.06B	1.93B	1.32B	1.41B	2.45B
Total Current Assets	32.67B	23.28B	7.97B	126B	115B
Gross Property Plant And Equipment	53.71B	61.04B	61.73B	52.38B	55.27B
Accumulated Depreciation	-15.64B	-20.29B	-23.04B	-25.45B	-27.71B
Net Property Plant And Equipment	38.07B	40.74B	38.68B	26.93B	27.57B
Long-term Investments	2.61B	2.62B	2.6B	11.54B	31.25B
Other Intangibles, Total	605M	675M	687M	958M	1.16B
Accounts Receivable Long-Term	-	340	-	180	240
Loans Receivable Long-Term	2.68B	-	-	-	-
Deferred Charges Long-Term	-	-	1.13B	1.88B	2.02B
Other Long-Term Assets, Total	1.23B	958M	1.43B	1.11B	1.66B
Total Assets	77.87B	68.27B	52.5B	169B	179B
Liabilities
Accounts Payable, Total	572M	642M	223M	478M	692M
Accrued Expenses, Total	220M	241M	307M	343M	594M
Short-term Borrowings	-	3B	4.55B	990M	3.49B
Current Portion of Long-Term Debt	3B	6.05B	-	-	-
Current Portion of Leases	54.65M	94.95M	57.89M	102M	280M
Current Income Taxes Payable	-	-	-	56.04M	-
Other Current Liabilities	2.76B	745M	1.75B	3.13B	1.95B
Total Current Liabilities	6.6B	10.77B	6.88B	5.1B	7.01B
Long-Term Debt	6.05B	-	4.5B	8.06B	25.59B
Long-Term Leases	52.26M	81.89M	26.1M	85.28M	192M
Pension & Other Post Retirement Benefits	2.32B	2.15B	2.67B	2.86B	2.45B
Deferred Tax Liability Non Current	92.54M	1.63B	1.55B	337M	824M
Other Non Current Liabilities	465M	534M	732M	743M	897M
Total Liabilities	15.59B	15.17B	16.37B	17.18B	36.97B
Preferred Stock Non Redeemable	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	10.31B	10.31B	10.31B	11.65B	11.66B
Additional Paid In Capital	133B	15.47B	15.75B	152B	22.91B
Retained Earnings	-82.05B	20.21B	4.89B	-13.54B	106B
Treasury Stock	-	-	-891M	-891M	-891M
Comprehensive Income and Other	1.48B	7.12B	6.06B	2.78B	2.26B
Total Common Equity	62.28B	53.11B	36.13B	152B	142B
Total Equity	62.28B	53.11B	36.13B	152B	142B
Total Liabilities And Equity	77.87B	68.27B	52.5B	169B	179B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20.63M	20.63M	20.55M	23.22M	23.24M
ECS Total Common Shares Outstanding	20.63M	20.63M	20.55M	23.22M	23.24M
Book Value / Share	3.02K	2.57K	1.76K	6.53K	6.11K
Tangible Book Value	61.68B	52.43B	35.44B	151B	141B
Tangible Book Value Per Share	2.99K	2.54K	1.72K	6.49K	6.06K
Total Debt	9.16B	9.23B	9.13B	9.24B	29.56B
Net Debt	-21.08B	-8.02B	4.15B	-115B	-77.36B
Debt Equivalent Oper. Leases	-	-	-	-	-
Inventories - Raw Materials, Total	29.46M	52.16M	53.55M	42.4M	1.18B
Inventories - Work In Process, Total	374M	425M	-	-	1.19B
Inventories - Finished Goods, Total	318M	354M	136M	232M	123M
Inventories - Others	-680	-800	-640	-200	-470
Land - (BS)	15.47B	22.57B	22.7B	12.19B	12.19B
Buildings, Total	12.01B	12.13B	12.13B	12.13B	12.13B
Machinery, Total	10.87B	11.42B	11.51B	12.16B	12.7B
Accumulated Allowance for Doubtful Accounts (Supple)	526K	526K	526K	2.33M	3.28M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-15.04B	-15.06B	-15.92B	-22.03B	-13.82B
Depreciation & Amortization - CF	3.41B	4.95B	2.78B	2.57B	2.55B
Amortization of Goodwill and Intangible Assets - (CF)	102M	101M	118M	124M	162M
Depreciation & Amortization, Total	3.51B	5.05B	2.89B	2.69B	2.71B
(Gain) Loss From Sale Of Asset	913K	162M	-3.47M	3.15B	124M
(Gain) Loss on Sale of Investments - (CF)	-5.28M	-7.1M	-2.83M	2.47B	-3.99B
Asset Writedown & Restructuring Costs	15.96M	19.49M	7.05M	8.71M	1K
Stock-Based Compensation (CF)	128M	97.61M	8.31M	-	-
Provision and Write-off of Bad Debts	-	-	-	1.8M	950K
Other Operating Activities, Total	-130M	669M	869M	614M	1.12B
Change In Accounts Receivable	24.54M	16.86M	-44.26M	81.72M	-281M
Change In Inventories	-600M	-109M	641M	-85.32M	-1.51B
Change In Accounts Payable	-154M	70.7M	-418M	255M	214M
Change in Other Net Operating Assets	1.64B	-2.63B	997M	80.47M	-5.15B
Cash from Operations	-10.61B	-11.72B	-10.97B	-12.77B	-20.59B
Capital Expenditure	-699M	-1.52B	-731M	-1.01B	-2.49B
Sale of Property, Plant, and Equipment	-	836M	19.86M	7.38B	1.36M
Sale (Purchase) of Intangible assets	-76.17M	-191M	-1.26B	-1.16B	-503M
Investment in Marketable and Equity Securities, Total	-25.49B	13.4B	11.5B	-134B	4.58B
Net (Increase) Decrease in Loans Originated / Sold - Investing	701M	95.41M	1.58B	999M	-1.63B
Other Investing Activities, Total	-310M	-542M	-70M	-55.25M	-303M
Cash from Investing	-25.88B	12.07B	11.04B	-127B	-341M
Long-Term Debt Issued, Total	-	-	-	10.05B	26.68B
Total Debt Issued	-	-	-	10.05B	26.68B
Long-Term Debt Repaid, Total	-26.98B	-102M	-101M	-10.16B	-2.75B
Total Debt Repaid	-26.98B	-102M	-101M	-10.16B	-2.75B
Issuance of Common Stock	-	-	-	139B	362M
Repurchase of Common Stock	-	-	-891M	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	80.51M	54.38M	139M	-2.18B	-1.93M
Cash from Financing	-26.9B	-47.81M	-853M	137B	24.28B
Foreign Exchange Rate Adjustments	64.87M	95.9M	12.06M	128M	-23.32M
Net Change in Cash	-63.33B	402M	-775M	-3.22B	3.33B
Supplemental Items
Cash Interest Paid	254M	273M	379M	484M	324M
Cash Income Tax Paid (Refund)	320M	41.99M	-19.73M	-14.38M	577M
Levered Free Cash Flow	-6.23B	-11.88B	-5.57B	-7.97B	-20.98B
Unlevered Free Cash Flow	-6.2B	-11.7B	-5.32B	-7.68B	-20.16B
Change In Net Working Capital	-849M	5.52B	-3.71B	-2.13B	6.59B
Net Debt Issued / Repaid	-26.98B	-102M	-101M	-107M	23.92B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-10.01	-13.02	-16.44	-9.33	-7.64
Return on Total Capital	-10.61	-14.23	-18.45	-10.02	-7.99
Return On Equity %	-21.58	-26.11	-35.68	-23.46	-9.41
Return on Common Equity	-21.58	-26.11	-35.68	-23.46	-9.41
Margin Analysis
Gross Profit Margin %	67.42	56.26	31.53	29.74	23.82
SG&A Margin	75.54	83.6	155.99	156.21	116.99
EBITDA Margin %	-183.39	-174.96	-388.69	-438.96	-329.07
EBITA Margin %	-234.83	-260.16	-471.76	-520.39	-374.38
EBIT Margin %	-236.37	-261.9	-475.3	-524.33	-377.25
Income From Continuing Operations Margin %	-227.07	-259.08	-476.43	-699	-245.33
Net Income Margin %	-227.07	-259.08	-476.43	-699	-245.33
Net Avail. For Common Margin %	-227.07	-259.08	-476.43	-699	-245.33
Normalized Net Income Margin	-144.09	-160.09	-298.11	-317.06	-201.84
Levered Free Cash Flow Margin	-93.98	-204.29	-166.62	-252.86	-372.35
Unlevered Free Cash Flow Margin	-93.64	-201.28	-159.22	-243.49	-357.7
Asset Turnover
Asset Turnover	0.07	0.08	0.06	0.03	0.03
Fixed Assets Turnover	0.17	0.15	0.08	0.1	0.21
Receivables Turnover (Average Receivables)	16.57	15.33	8.51	8.45	11.95
Inventory Turnover (Average Inventory)	5.33	3.35	4.64	10.31	4.23
Short Term Liquidity
Current Ratio	4.95	2.16	1.16	24.81	16.45
Quick Ratio	4.68	1.65	0.79	24.44	15.42
Operating Cash Flow to Current Liabilities	-1.61	-1.09	-1.59	-2.5	-2.94
Days Sales Outstanding (Average Receivables)	22.03	23.8	42.9	43.31	30.54
Days Outstanding Inventory (Average Inventory)	68.46	108.96	78.62	35.5	86.19
Average Days Payable Outstanding	85.81	83.49	95.85	55.81	36.79
Cash Conversion Cycle (Average Days)	4.68	49.27	25.67	23.01	79.94
Long Term Solvency
Total Debt/Equity	14.7	17.37	25.28	6.09	20.81
Total Debt / Total Capital	12.82	14.8	20.18	5.74	17.23
LT Debt/Equity	9.8	0.15	12.53	5.37	18.16
Long-Term Debt / Total Capital	8.54	0.13	10	5.06	15.03
Total Liabilities / Total Assets	20.02	22.21	31.18	10.17	20.66
EBIT / Interest Expense	-425.04	-54.45	-40.11	-34.95	-16.09
EBITDA / Interest Expense	-329.77	-36.37	-32.8	-29.26	-14.04
(EBITDA - Capex) / Interest Expense	-348.74	-41.83	-34.64	-31.39	-15.92
Total Debt / EBITDA	-0.75	-0.91	-0.7	-0.67	-1.59
Net Debt / EBITDA	1.74	0.79	-0.32	8.29	4.17
Total Debt / (EBITDA - Capex)	-0.71	-0.79	-0.67	-0.62	-1.4
Net Debt / (EBITDA - Capex)	1.64	0.69	-0.3	7.72	3.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	112.28	-12.24	-42.52	-5.68	78.76
Gross Profit, 1 Yr. Growth %	342.32	-26.77	-67.78	-11.03	43.16
EBITDA, 1 Yr. Growth %	-15.28	-16.27	27.7	6.52	34.01
EBITA, 1 Yr. Growth %	-10.86	-2.77	4.23	4.05	28.6
EBIT, 1 Yr. Growth %	-11.06	-2.76	4.32	4.05	28.62
Earnings From Cont. Operations, 1 Yr. Growth %	-18.17	0.14	5.7	38.39	-37.26
Net Income, 1 Yr. Growth %	-18.17	0.14	5.7	38.39	-37.26
Normalized Net Income, 1 Yr. Growth %	-15.91	-2.49	7.04	0.32	13.8
Diluted EPS Before Extra, 1 Yr. Growth %	-39.03	0.17	5.97	37.04	-43.91
Accounts Receivable, 1 Yr. Growth %	-5.96	-4.3	11.85	-20.13	84.61
Inventory, 1 Yr. Growth %	573.77	15.4	-78.83	49.55	587.3
Net Property, Plant and Equip., 1 Yr. Growth %	-6.59	7.02	-5.05	-30.4	2.38
Total Assets, 1 Yr. Growth %	-33.84	-12.32	-23.11	221.73	5.97
Tangible Book Value, 1 Yr. Growth %	-19.36	-14.99	-32.41	325.37	-6.57
Common Equity, 1 Yr. Growth %	-19.25	-14.73	-31.98	319.93	-6.39
Cash From Operations, 1 Yr. Growth %	-21.66	10.41	-6.37	16.34	61.25
Capital Expenditures, 1 Yr. Growth %	-77.45	118.27	-52.05	37.92	147.31
Levered Free Cash Flow, 1 Yr. Growth %	-40.53	90.77	-53.12	43.14	163.23
Unlevered Free Cash Flow, 1 Yr. Growth %	-40.75	88.66	-54.53	44.24	162.61
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	91.78	36.49	-28.97	-26.37	29.85
Gross Profit, 2 Yr. CAGR %	180.65	79.97	-51.43	-46.46	12.86
EBITDA, 2 Yr. CAGR %	9.93	-15.78	3.4	16.63	19.48
EBITA, 2 Yr. CAGR %	11.33	-6.9	0.67	4.14	15.67
EBIT, 2 Yr. CAGR %	11.02	-7	0.72	4.19	15.68
Earnings From Cont. Operations, 2 Yr. CAGR %	-7.86	-9.48	2.88	20.95	-6.82
Net Income, 2 Yr. CAGR %	-7.86	-9.48	2.88	20.95	-6.82
Normalized Net Income, 2 Yr. CAGR %	-6.92	-9.45	2.16	3.62	6.85
Diluted EPS Before Extra, 2 Yr. CAGR %	-20.58	-21.86	3.01	20.54	-12.32
Accounts Receivable, 2 Yr. CAGR %	134.17	-5.13	3.46	-5.48	21.43
Inventory, 2 Yr. CAGR %	441.35	178.84	-50.58	-43.74	220.6
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.81	-0.02	0.8	-18.71	-15.59
Total Assets, 2 Yr. CAGR %	13	-23.84	-17.89	57.28	84.65
Tangible Book Value, 2 Yr. CAGR %	49.98	-17.2	-24.2	69.56	99.36
Common Equity, 2 Yr. CAGR %	48.92	-17.02	-23.84	69.01	98.26
Cash From Operations, 2 Yr. CAGR %	5.16	-7	1.68	4.37	36.97
Capital Expenditures, 2 Yr. CAGR %	-62.65	-29.84	2.3	-18.68	84.69
Levered Free Cash Flow, 2 Yr. CAGR %	-24.04	6.51	-5.43	-18.08	94.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	-24.18	5.73	-7.38	-19.02	94.63
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.71	47.79	2.31	-21.93	-1.04
Gross Profit, 3 Yr. CAGR %	47.52	79.34	1.43	-40.57	-25.69
EBITDA, 3 Yr. CAGR %	20.14	0.4	-3.24	4.43	22.16
EBITA, 3 Yr. CAGR %	26.11	6.41	-3.33	1.78	11.73
EBIT, 3 Yr. CAGR %	25.58	6.22	-3.37	1.82	11.76
Earnings From Cont. Operations, 3 Yr. CAGR %	59.23	-5.27	-4.68	13.57	-2.82
Net Income, 3 Yr. CAGR %	59.23	-5.27	-4.68	13.57	-2.82
Normalized Net Income, 3 Yr. CAGR %	60.36	-5.47	-4.26	1.54	6.91
Diluted EPS Before Extra, 3 Yr. CAGR %	44.24	-14.2	-13.52	13.31	-6.58
Accounts Receivable, 3 Yr. CAGR %	113.09	73.78	0.22	-5.09	18.15
Inventory, 3 Yr. CAGR %	204.01	223.39	18.06	-28.52	29.58
Net Property, Plant and Equip., 3 Yr. CAGR %	0.13	0.36	-1.73	-10.9	-12.21
Total Assets, 3 Yr. CAGR %	2.76	3.83	-23.6	29.44	37.88
Tangible Book Value, 3 Yr. CAGR %	11.55	24.12	-22.62	34.7	39.01
Common Equity, 3 Yr. CAGR %	11.36	23.66	-22.34	34.55	38.8
Cash From Operations, 3 Yr. CAGR %	36.43	6.88	-6.79	6.35	20.66
Capital Expenditures, 3 Yr. CAGR %	-59	-32.72	-38.2	13.01	17.82
Levered Free Cash Flow, 3 Yr. CAGR %	-20.14	3.25	-18.98	8.58	20.88
Unlevered Free Cash Flow, 3 Yr. CAGR %	-20.24	2.74	-20.2	7.36	19.87
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.17	12.58	-2.85	11.84	12.54
Gross Profit, 5 Yr. CAGR %	30.08	22.96	-5.41	10.58	5.85
EBITDA, 5 Yr. CAGR %	32.61	19.47	13.14	6.6	5.28
EBITA, 5 Yr. CAGR %	36.34	26.99	15.24	5.5	3.87
EBIT, 5 Yr. CAGR %	34.45	26.11	14.98	5.4	3.84
Earnings From Cont. Operations, 5 Yr. CAGR %	36.36	27.75	33.71	4.46	-5.54
Net Income, 5 Yr. CAGR %	36.36	27.75	33.71	4.46	-5.54
Normalized Net Income, 5 Yr. CAGR %	36.29	28.19	33.9	-1.93	0.04
Diluted EPS Before Extra, 5 Yr. CAGR %	5.24	3.66	26.06	-1.71	-13.03
Accounts Receivable, 5 Yr. CAGR %	21.65	-12.43	59.6	36.21	8.22
Inventory, 5 Yr. CAGR %	24.33	10.86	47	60.66	76.06
Net Property, Plant and Equip., 5 Yr. CAGR %	39.96	7.38	0.4	-7.75	-7.52
Total Assets, 5 Yr. CAGR %	6.1	5.18	-6.06	22.6	8.74
Tangible Book Value, 5 Yr. CAGR %	3.49	1.72	-4.43	40.62	12.99
Common Equity, 5 Yr. CAGR %	3.42	1.68	-4.34	40.12	12.98
Cash From Operations, 5 Yr. CAGR %	31.21	15.81	21.29	5.87	8.72
Capital Expenditures, 5 Yr. CAGR %	-24.16	-41.28	-40.9	-27.42	-4.25
Levered Free Cash Flow, 5 Yr. CAGR %	5.67	-14.61	-14.55	-5.88	14.92
Unlevered Free Cash Flow, 5 Yr. CAGR %	5.78	-14.86	-15.33	-6.59	14